Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/135343
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMorrissey, Ian-
dc.contributor.authorCantón, Rafael-
dc.contributor.authorVila Estapé, Jordi-
dc.contributor.authorGargallo Viola, Domingo-
dc.contributor.authorZsolt, Ilonka-
dc.contributor.authorGarcía Castillo, María-
dc.contributor.authorLópez, Yuly-
dc.date.accessioned2019-06-18T15:22:25Z-
dc.date.available2019-06-18T15:22:25Z-
dc.date.issued2019-05-28-
dc.identifier.issn1746-0913-
dc.identifier.urihttp://hdl.handle.net/2445/135343-
dc.description.abstractAim: To explore the antibacterial spectrum of ozenoxacin and compare its in vitro activity with that of other antibacterial agents. Materials & methods: In 2010, 10,054 isolates were collected from 128 centers worldwide. Minimum inhibitory concentrations against Gram-positive and Gram-negative isolates were determined for 23 and 13 antibacterial agents, respectively. Results: Ozenoxacin exhibited high in vitro activity against susceptible, and methicillin- or levofloxacin-resistant, Gram-positive bacteria. Ozenoxacin was one or two dilutions less active against Enterobacteriaceae isolates, except for Escherichia coli, than other quinolones. Conclusion: Ozenoxacin is a potent antimicrobial agent mainly against susceptible and resistant strains of Gram-positive isolates (staphylococci and streptococci), and shows activity against some Gram-negative isolates.-
dc.format.extent15 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFuture Science Group-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.2217/fmb-2019-0089-
dc.relation.ispartofFuture Microbiology, 2019-
dc.relation.urihttp://dx.doi.org/ 10.2217/fmb-2019-0089-
dc.rightscc by-nc-nd (c) Morrissey et al., 2019-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/-
dc.sourceArticles publicats en revistes (ISGlobal)-
dc.subject.classificationInfeccions respiratòries-
dc.subject.classificationAntibiòtics-
dc.subject.otherRespiratory infections-
dc.subject.otherAntibiotics-
dc.titleMicrobiological profile of ozenoxacin-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2019-06-14T09:57:25Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
MorrisseyI_Future_Microbiol_2019.pdf1.33 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons